ELIXINOL WELLNESS LIMITED (EXL)
AI Coverage Rating: Active
ASX AI Signals has generated 3 signal for EXL during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest EXL Signals | |
| 26/05/2026 | SELL |
| 14/05/2026 | BUY |
| 06/05/2026 | SELL |
EXL Share Price | |
| Current Price | $0.007 |
| 52 Week High | $0.020 |
| 52 Week Low: | $0.006 |
| Trading at (% of 52 Week High) | 35.00% |
Business Overview
Elixinol Wellness Limited (ASX: EXL) is a company that develops and sells hemp-based products, including CBD oils, capsules, and skincare items. It operates in the health and wellness sector, targeting consumers seeking natural remedies and supplements. The company is based in Australia and serves various international markets.
ASX Sector Overview
Sector: Household & Personal Products
The Household & Personal Products sector on the ASX includes companies that manufacture and sell items used for daily personal care and household cleaning. This sector covers products such as toiletries, cosmetics, skincare, cleaning agents, and hygiene supplies. Companies in this sector often invest in research and development to create innovative and safe products that meet consumer needs. The sector is influenced by consumer trends, regulatory standards, and shifts towards sustainability and natural ingredients. It plays a key role in everyday life by providing essential goods for personal and home use.
Latest AI Recommendation
The SELL recommendation for ELIXINOL WELLNESS LIMITED (EXL) is supported by the extremely low current price indicating potential distress or undervaluation, combined with market signals suggesting downward momentum. However, some uncertainty remains due to limited publicly available financial data and potential volatility in the wellness sector.
Latest ELIXINOL WELLNESS LIMITED(EXL) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial